Here are relevant reports on : rna-therapeutics-market
-
In Situ Hybridization Market by Offering (Consumables, Instruments, Software), Technology (FISH (DNA FISH, RNA, PNA), CISH), Application (Cancer Diagnostics, Research, Discovery), End User (Hospitals, Pharma & Biotech, Academia) - Global Forecast to 2030
The global in situ hybridization market, valued at US$1.55 billion in 2024, stood at US$1.64 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$2.35 billion by the end of the period. The growth in the field of in situ hybridization (ISH) is significantly driven by ongoing advancements in technology, including high-sensitivity probes, automated systems, and multiplexing solutions.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
UK Next-generation Sequencing Market by Product (Reagents, Kits, Platforms), Service (CHIP Sequencing, Whole Genome, Methyl, RNA Sequencing), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Application, Competition - Forecast to 2031
The UK next-generation sequencing market, valued at USD 0.73 billion in 2025, stood at USD 0.80 billion in 2026 and is projected to advance at a resilient CAGR of 14.8% from 2026 to 2031, culminating in a forecasted valuation of USD 1.59 billion by the end of the period. The report profiles key players such as Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), Oxford Nanopore Technologies plc. (UK), QIAGEN (Netherlands), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), PacBio (US), and Eurofins Scientific (Luxembourg).
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Oligonucleotide Synthesis Market by Offerings (Synthesis products [Consumables, Equipment], Synthesized Oligos (Type [DNA, RNA], Oligo-based Drugs (Type [ASO, siRNA), Therapy Area [Rare Diseases, Neurology, Oncology], Competition - Global Forecast to 2031
The global oligonucleotide synthesis market is projected to reach USD 32.72 billion by 2031, growing at a CAGR of 17.4% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Agriculture Biotechnology Market (Agriculture-Themed Microarrays Lab-on-Chip Devices RNA Interference Assays, Agriculture-Derived Biofuels Chemicals Transgenic Seeds) - 2018 By Application & Geography
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Agriculture Biotechnology Market (Agriculture-Themed Microarrays Lab-on-Chip Devices RNA Interference Assays, Agriculture-Derived Biofuels Chemicals Transgenic Seeds) - 2018 By Application & Geography
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Blood Collection Devices Market by Product (Tubes (Plasma (EDTA, Heparin), Serum), Needles & Syringes, Blood Bags, Monitors), Method (Manual, Automated), Application (Diagnostics, Therapeutics), End User (Hospitals, Blood Banks) - Global Forecast to 2030
The global blood collection devices market, valued at US$8.61 billion in 2024, stood at US$9.13 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2024 to 2030, culminating in a forecasted valuation of US$13.02 billion by the end of the period. The growing number of accidents and trauma cases has further increased the need for rapid and reliable blood collection for diagnostics and emergency care.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Custom Antibody Market by Service (Development, Purification, Fragmentation, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology, Infectious, CVD) - Global Forecast to 2029
The global custom antibody market, valued at US$539 million in 2023, stood at US$579 million in 2024 and is projected to advance at a resilient CAGR of 9.2% from 2024 to 2029, culminating in a forecasted valuation of US$901 million by the end of the period. The market's growth is mainly driven by government funding and support for research in antibody-related fields, coupled with the expansion into translational medicine.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
mRNA Therapeutics Market by Product (Vaccines, Drugs), Application (Oncology, Rare Diseases, Infectious Diseases, Other Applications), End User (Hospitals & Clinics, Research Settings) - Global Forecast to 2027
The global mRNA therapeutics market is projected to reach USD ~35 billion by 2027 from USD 32 billion in 2022, at a CAGR of ~2% between 2022 and 2027.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Personalized Medicine Market by Product (Personalized Medicine Testing, Personalized Medicine Therapeutics), Application (Oncology, Neurology, Cardiology) - Global Forecast to 2027
The global personalized medicine market is projected to reach USD ~500 billion by 2027 from USD 300 Billion in 2022, at a CAGR of 11% during the forecast period
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020
The global virus filtration market size is projected to grow at a CAGR of 12.3%. Virus filtration is an important operation in the pharmaceutical industry, as it not only ensures if the products are adequately purified and fit for consumption, but also helps to optimize process economics and prevent loss of valuable product.
- Published: April 2016
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
